Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page
- Check6 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page remains a 403 Forbidden error page; its footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record. This indicates an access-control issue rather than a content update.SummaryDifference19%

- Check62 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6, indicating a new build of the page. No substantive content changes are visible in this update.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision tag has been updated from v3.6.4 to v3.6.5, representing a backend/content update to the page. It does not alter any study details or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.